# This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.

> **NCT05082428** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 252 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05082428
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-30
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2024-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05082428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05082428, "This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05082428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*